Herbreteau D, Guichard J P, Gobin Y P, Aymard A, Casasco A, Borsik M, Houdard E, Enjolras O, Riche M C, Reizine D
Consultation Multidisciplinaire des Angiomes, Hôpital Lariboisière, Paris.
Ann Otolaryngol Chir Cervicofac. 1992;109(5):258-63.
Cystic lymphatic malformations are hemodynamically inactive vascular malformations of the lymphatic compartment. Over a 9 years period, 52 patients with superficial cystic lymphatic malformations of the head and neck underwent embolization by direct injections of Ethibloc (Ethicon, Ethnon Laboratories, Neuilly/France) under fluoroscopic control. Results were graded as excellent or good in 57% of patients after embolization alone. Treatment was completed by surgery in 19% of patients. Embolization was considered a failure in 24% (12 patients), although 10 of these patients showed regression of the cystic component after embolization. This safe, efficacious percutaneous technique has emerged as the first treatment to be considered for cystic lymphatic malformations.
囊性淋巴管畸形是淋巴系统血流动力学无活性的血管畸形。在9年期间,52例头颈部浅表囊性淋巴管畸形患者在透视控制下通过直接注射Ethibloc(Ethicon公司,Ethnon实验室,法国纳伊)进行栓塞治疗。单独栓塞后,57%的患者结果被评为优秀或良好。19%的患者通过手术完成治疗。24%(12例患者)的栓塞治疗被认为失败,尽管其中10例患者在栓塞后囊性成分出现消退。这种安全、有效的经皮技术已成为囊性淋巴管畸形首先考虑的治疗方法。